West Pharmaceutical Services Inc (WST)

$318.22 $3.22 (1.01%) 4:40 PM 12/11/24
NYSE | $USD | Medical Instruments & Supplies

Stock Data

  • Market Cap

    $23.36B
  • Day's Range

    $320.71 - $324.56
  • Volume

    389,110
  • 52 Week Low / High

    $264.65 - $412.94
  • PE Ratio

    47.85x
  • PEG Ratio

    6.02
  • Dividend Frequency

    quarterly

WST's Dividend
$0.21
Amount
0.26%
Dividend Yield
Nov 20
Payment Date
$0.84
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
5
Strong Buy
2
Buy
3
Hold
0
Sell
0
Strong Sell
$400.71
Target Price

Company News

  • Earnings Preview: West Pharmaceutical Services (WST) Q3 Earnings Expected to Decline — Oct 17th, 2024

    West Pharmaceutical Services (WST) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual result...

  • West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards — Oct 9th, 2024

    EXTON, Pa., Oct. 9, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that it has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with F...

  • What's in Store for West Pharmaceutical in Q3 Earnings? — Oct 21st, 2024

    West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, d...

  • Earnings Preview: West Pharmaceutical Services (WST) Q3 Earnings Expected to Decline — Oct 17th, 2024

    West Pharmaceutical Services (WST) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual result...

  • West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards — Oct 9th, 2024

    EXTON, Pa., Oct. 9, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that it has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with F...

  • West to Host Third-Quarter 2024 Conference Call — Oct 10th, 2024

    EXTON, Pa., Oct. 10, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 24, 2024, ...

  • Earnings Preview: West Pharmaceutical Services (WST) Q3 Earnings Expected to Decline — Oct 17th, 2024

    West Pharmaceutical Services (WST) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual result...

  • West to Host Third-Quarter 2024 Conference Call — Oct 10th, 2024

    EXTON, Pa., Oct. 10, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 24, 2024, ...

  • West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference — Oct 7th, 2024

    EXTON, Pa., Oct. 7, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Milan, Italy to showcase leadership and expertise on industry challen...

  • West to Host Third-Quarter 2024 Conference Call — Oct 10th, 2024

    EXTON, Pa., Oct. 10, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 24, 2024, ...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • What's in Store for West Pharmaceutical in Q3 Earnings? — Oct 21st, 2024

    West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, d...

  • West to Host Third-Quarter 2024 Conference Call — Oct 10th, 2024

    EXTON, Pa., Oct. 10, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 24, 2024, ...

  • Earnings Preview: West Pharmaceutical Services (WST) Q3 Earnings Expected to Decline — Oct 17th, 2024

    West Pharmaceutical Services (WST) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual result...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • What's in Store for West Pharmaceutical in Q3 Earnings? — Oct 21st, 2024

    West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, d...

  • What's in Store for West Pharmaceutical in Q3 Earnings? — Oct 21st, 2024

    West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, d...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference — Oct 7th, 2024

    EXTON, Pa., Oct. 7, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Milan, Italy to showcase leadership and expertise on industry challen...

  • West to Host Third-Quarter 2024 Conference Call — Oct 10th, 2024

    EXTON, Pa., Oct. 10, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 24, 2024, ...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards — Oct 9th, 2024

    EXTON, Pa., Oct. 9, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that it has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with F...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards — Oct 9th, 2024

    EXTON, Pa., Oct. 9, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that it has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with F...

  • West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards — Oct 9th, 2024

    EXTON, Pa., Oct. 9, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that it has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with F...

  • Earnings Preview: West Pharmaceutical Services (WST) Q3 Earnings Expected to Decline — Oct 17th, 2024

    West Pharmaceutical Services (WST) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual result...

  • West to Host Third-Quarter 2024 Conference Call — Oct 10th, 2024

    EXTON, Pa., Oct. 10, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 24, 2024, ...

  • What's in Store for West Pharmaceutical in Q3 Earnings? — Oct 21st, 2024

    West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, d...

  • West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference — Oct 7th, 2024

    EXTON, Pa., Oct. 7, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Milan, Italy to showcase leadership and expertise on industry challen...

  • Earnings Preview: West Pharmaceutical Services (WST) Q3 Earnings Expected to Decline — Oct 17th, 2024

    West Pharmaceutical Services (WST) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual result...

  • West to Host Third-Quarter 2024 Conference Call — Oct 10th, 2024

    EXTON, Pa., Oct. 10, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 24, 2024, ...

  • West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards — Oct 9th, 2024

    EXTON, Pa., Oct. 9, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that it has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with F...

  • What's in Store for West Pharmaceutical in Q3 Earnings? — Oct 21st, 2024

    West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, d...

  • Earnings Preview: West Pharmaceutical Services (WST) Q3 Earnings Expected to Decline — Oct 17th, 2024

    West Pharmaceutical Services (WST) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual result...

  • West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference — Oct 7th, 2024

    EXTON, Pa., Oct. 7, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Milan, Italy to showcase leadership and expertise on industry challen...

  • What's in Store for West Pharmaceutical in Q3 Earnings? — Oct 21st, 2024

    West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, d...

  • West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards — Oct 9th, 2024

    EXTON, Pa., Oct. 9, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that it has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with F...

  • What's in Store for West Pharmaceutical in Q3 Earnings? — Oct 21st, 2024

    West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, d...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • Earnings Preview: West Pharmaceutical Services (WST) Q3 Earnings Expected to Decline — Oct 17th, 2024

    West Pharmaceutical Services (WST) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual result...

  • What's in Store for West Pharmaceutical in Q3 Earnings? — Oct 21st, 2024

    West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, d...

  • What's in Store for West Pharmaceutical in Q3 Earnings? — Oct 21st, 2024

    West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, d...

  • What's in Store for West Pharmaceutical in Q3 Earnings? — Oct 21st, 2024

    West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, d...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • Earnings Preview: West Pharmaceutical Services (WST) Q3 Earnings Expected to Decline — Oct 17th, 2024

    West Pharmaceutical Services (WST) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual result...

  • What's in Store for West Pharmaceutical in Q3 Earnings? — Oct 21st, 2024

    West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, d...

  • West to Host Third-Quarter 2024 Conference Call — Oct 10th, 2024

    EXTON, Pa., Oct. 10, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 24, 2024, ...

  • West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards — Oct 9th, 2024

    EXTON, Pa., Oct. 9, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that it has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with F...

  • What's in Store for West Pharmaceutical in Q3 Earnings? — Oct 21st, 2024

    West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%. WST’s earnings beat estimates in three of the trailing four quarters and missed once, d...

Similar Stocks

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free